News

Nectero Therapeutics Reports Positive Two-Year Safety Data for EAST System in Abdominal Aortic Aneurysm Trial

2 min

Novo Nordisk's Oral Semaglutide Shows Promise as First GLP-1 Therapy for Children with Type 2 Diabetes

Type 2 Diabetes · 4 min

Greenwich LifeSciences GLSI-100 Abstract Accepted at ASCO 2026 for Breast Cancer Immunotherapy Trial

2 min

Mabwell's 9MW2821 Becomes First Nectin-4 ADC to Enter Phase III Trial for Triple-Negative Breast Cancer

2 min

ClearPoint Neuro Receives FDA Clearance for Velocity Alpha MR High Speed Surgical Drill System

FDA · 2 min

Vistagen Receives FDA Approval to Advance Refisolone Phase 2 Trial for Menopause Hot Flashes

FDA · 2 min

Avaí Bio Receives First FDA Clearance for Cellular Rejuvenation Trial as Anti-Aging Market Reaches $120 Billion

FDA · Anti-aging/Longevity/Cellular Rejuvenation · 3 min

Cipla Receives FDA Approval for First Generic Ventolin HFA (Albuterol Sulfate) - AB-Rated Therapeutic Equivalent

FDA · 2 min

Dupixent Becomes First Biologic Approved for Chronic Spontaneous Urticaria in Children Ages 2-11

2 min

Oncology Data Landscape 2026: Key Trends & Upcoming Readouts

oncology · 8 min

ReDI 2026: FDA Regulatory Strategies Conference Recap

general · 5 min

BioNJ BioPartnering Conference 2026: Biotech & Partnering

biotech · 4 min